loading...

COA Instruments Distributed by Mapi Research Trust

Filter by:

default distrib

CMCQ / Comorbid Medical Conditions Questionnaire Comorbid Medical Conditions Questionnaire

MacLean EW, Palsson OS, Turner MJ, Whitehead WE et al.

To measure non-gastrointestinal symptoms that co-exist with Irritable Bowel Syndrome (IBS)

Therapeutic indications : Irritable Bowel Syndrome

default distrib

Contilife® / Quality of Life Assessment Questionnaire Concerning Urinary Incontinence Quality of Life Assessment Questionnaire Concerning Urinary Incontinence

Sanofi Aventis, Mapi et al.

To assess the impact of urinary incontinence on quality of life

Therapeutic indications : Urinary Incontinence

default distrib

CQLQ / Caregiver Quality Of Life Questionnaire (Physical & Emotional) Caregiver Quality Of Life Questionnaire (Physical & Emotional)

Bates GE, Hashimi AK, Bressler T, Zajac J, Hesdorffer M, Taub RN et al.

To assess physical and emotional quality of life in caregivers

Therapeutic indications : All

default distrib

CQLQ© / Cough Quality of Life Questionnaire Cough Quality of Life Questionnaire

Irwin RS, Fletcher KE, French CT et al.

Designed to reflect the impact of cough on health-related quality of life in patients complaining of acute and chronic cough

Therapeutic indications : Cough

default distrib

CSDD / Cornell Scale for Depression in Dementia Cornell Scale for Depression in Dementia

Alexopoulos GS, Abrams RC, Young RC, Shamoian CA et al.

To detect signs and symptoms of depression in both demented and nondemented patients

Therapeutic indications : Depression

default distrib

CUSPAD / Columbia University Scale for Psychopathology in Alzheimer's Disease Columbia University Scale for Psychopathology in Alzheimer's Disease

Devanand DP, Miller L, Richards M, Marder K, Bell K, Mayeux R, Stern Y et al.

To screen and evaluate psychopathology in Alzheimer's Disease (AD)

Therapeutic indications : Alzheimer Disease

default distrib

D-FIS / Daily Fatigue Impact Scale Daily Fatigue Impact Scale

Fisk JD et al.

To measure the impact of fatigue on the daily lives of persons

Therapeutic indications : Fatigue

default distrib

DAD / Disability Assessment for Dementia Disability Assessment for Dementia

Gauthier L, Gelinas I et al.

To quantitatively measure functional abilities in activities of daily living (ADL) in individuals with cognitive impairments such as dementia

Therapeutic indications : Alzheimer Disease, Dementia

default distrib

DAS / DAS-28 CRP / Disease Activity Score - C-Reactive Protein Disease Activity Score - C-Reactive Protein

van Riel PL et al.

To judge disease activity in clinical practice

Therapeutic indications : Arthritis, Rheumatoid

default distrib

DAS / DAS-28 ESR / Disease Activity Score - Erythrocyte Sedimentation Rate Disease Activity Score - Erythrocyte Sedimentation Rate

van Riel PL et al.

To judge disease activity in clinical practice

Therapeutic indications : Arthritis, Rheumatoid

default distrib

DAS-3 / Diabetes Attitude Scale (third version) Diabetes Attitude Scale (third version)

Anderson RM, Gruppen LD, Fitzgerald JT, Funnell MM et al.

To assess general diabetes-related attitudes

Therapeutic indications : Diabetes Mellitus

default distrib

DBAS / Dysfunctional Beliefs and Attitudes about Sleep Dysfunctional Beliefs and Attitudes about Sleep

Morin CM et al.

To evaluate sleep/insomnia-related cognitions

Therapeutic indications : Sleep Disorders (includes apnea)

default distrib

DBAS-16 / Dysfunctional Beliefs and Attitudes about Sleep - 16 Dysfunctional Beliefs and Attitudes about Sleep - 16

Morin CM et al.

To evaluate sleep/insomnia-related cognitions

Therapeutic indications : Sleep Disorders (includes apnea)

default distrib

DCP / Diabetes Care Profile Diabetes Care Profile

Fitzgerald JT, Davis WJ, Connell CM, Hess GE, Funnell MM, Hiss RG et al.

To assess the social and psychological factors related to diabetes and its treatment

Therapeutic indications : Diabetes Mellitus

default distrib

DES / Diabetes Empowerment Scale Diabetes Empowerment Scale

Anderson RM, Funnell MM, Fitzgerald JT, Marrero DG et al.

To assess diabetes-related psychosocial self-efficacy

Therapeutic indications : Diabetes Mellitus

default distrib

DES-SF / Diabetes Empowerment Scale Short Form Diabetes Empowerment Scale Short Form

Anderson RM, Oh MS, Fitzgerald JT, Gruppen LD, Funnell MM et al.

To assess diabetes-related psychosocial self-efficacy

Therapeutic indications : Diabetes Mellitus

default distrib

DFS / Diabetic Foot Ulcer Scale Diabetic Foot Ulcer Scale

Janssen Global Services, LLC (USA), Mapi et al.

To assess the impact of diabetic foot ulcers and their treatment on quality of life from the patient’s perspective.

Therapeutic indications : Diabetes Mellitus, Leg Ulcer

default distrib

DFS-SF / Diabetic Foot Ulcer Scale - Short Form Diabetic Foot Ulcer Scale - Short Form

Janssen Global Services, LLC (USA), Mapi et al.

To assess the impact of diabetic foot ulcers and their treatment on patients’ quality of life

Therapeutic indications : Diabetes Mellitus, Leg Ulcer

default distrib

DiabMedSat / Diabetes Medication Satisfaction Diabetes Medication Satisfaction

Novo Nordisk (Denmark) et al.

To measure diabetes treatment satisfaction, applicable to a wide range of diabetes therapies

Therapeutic indications : Diabetes Mellitus

default distrib

DIVA / Déterminants des Intentions de VAccination Déterminants des Intentions de VAccination

Mapi, Société Française de Médecine Générale (SFMG) et al.

To assess primary care physician's (PCPs) attitudes and beliefs toward vaccination

Therapeutic indications : All

1
2
3
4 (current)
5
6
7